Skip to main content
Clinical Trials/NCT03288766
NCT03288766
Terminated
Not Applicable

A Single-Arm Prospective, Multi-Centered Study to Assess the SHERLOCK 3CG™ Diamond Tip Confirmation System

C. R. Bard8 sites in 2 countries232 target enrollmentApril 19, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Indication for Peripheral Intravenous Catheterization
Sponsor
C. R. Bard
Enrollment
232
Locations
8
Primary Endpoint
Rate of successful PICC tip placement within the lower third of the superior vena cava (SVC) or in the cavoatrial junction (CAJ) using SLM2
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

This study is a single-arm, prospective, multi-center study to assess clinical performance of the SHERLOCK 3CG™ Diamond Tip Confirmation System (TCS) with MODUS II software for confirming correct tip position of peripherally inserted central catheters (PICCs) in adult subjects with altered cardiac rhythm.

Detailed Description

This study is intended to confirm the accuracy of the SHERLOCK 3CG™ Diamond TCS with the addition of MODUS II (SLM2) software to eliminate the need for post-procedural chest x-ray (CXR) in adult subjects with cardiac abnormalities that alter presentation of the P-wave. Atrial fibrillation will be the primary target while data on pacemaker driven rhythms and other arrhythmia types will also be collected to explore overall performance.

Registry
clinicaltrials.gov
Start Date
April 19, 2018
End Date
June 15, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
C. R. Bard
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female, ≥ 21 years of age with altered cardiac rhythm (no recognizable P-wave on standard ECG) with diagnosis of specific arrhythmia type or identification of pacemaker driven rhythms as defined below:
  • Atrial fibrillation with history of diagnosis per 12-lead ECG in medical record or diagnosed via bedside telemetry by study team RN at assessment, or
  • All other arrhythmias (including but not limited to atrial flutter, PAC, PVC, PJC, tachycardia, AV Block, BB Block) with history of diagnosis per 12-lead ECG in medical record or diagnosed via bedside telemetry by cardiac unit RN at assessment, or retrospectively by site cardiologist, or
  • Pacemaker driven rhythm with temporary or permanent pacemaker device in place;
  • Subject requires PICC placement as part of standard of care;
  • Subject or Legally Authorized Representative (LAR) has signed an Informed Consent Form (ICF).

Exclusion Criteria

  • Subject has a contraindication to PICC placement as listed in the Instructions for Use (IFU) to include:
  • The presence of bacteremia or septicemia (known or suspected),
  • The patient's body size is insufficient to accommodate the size of the implanted device,
  • The patient is known or is suspected to be allergic to materials contained in the device,
  • Past irradiation of prospective insertion site,
  • Previous episodes of venous thrombosis or vascular surgical procedures at the prospective placement site,
  • Local tissue factors will prevent proper device stabilization and/or access;
  • Subjects who previously had a PICC in place and require a PICC exchange;
  • Subject has presence of active resting tremor (i.e. Parkinson's, Multiple Sclerosis, etc.) deemed by Investigator to have potential impact on procedure accuracy;
  • Subjects who are pregnant or think they may be pregnant.

Outcomes

Primary Outcomes

Rate of successful PICC tip placement within the lower third of the superior vena cava (SVC) or in the cavoatrial junction (CAJ) using SLM2

Time Frame: The PICC insertion procedure is 60-90 mins in duration

Tip positioning is determined at bedside by the software via the Green Diamond Indicator (GDI+) and confirmed by CXR. PICC tip placement will be considered successful if it is determined to be in the lower 1/3 of the SVC or in the CAJ by an independent, blinded radiologist judging position retrospectively against pre-specified anatomical criteria.

Secondary Outcomes

  • Rate of successful PICC tip placement within the lower third of the superior vena cava (SVC) or in the cavoatrial junction (CAJ) using SLM2 in the absence of a GDI(The PICC insertion procedure is 60-90 mins in duration)
  • Percent agreement between the site readings of the CXR (standard of care) versus those completed by an independent, blinded radiologist(The PICC insertion procedure is 60-90 mins in duration)

Study Sites (8)

Loading locations...

Similar Trials